DUBLIN--(BUSINESS WIRE)--Aug 1, 2018--The "Structural Heart Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Structural heart devices by product are segmented into Repair devices and Replacement devices. The replacement devices segment held the largest market revenue in 2017 and expected to grow at a medium double digit CAGR from 2017 to 2024.

In structural heart repair devices segment, transcatheter repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024.

Among transcatheter repair devices, Transcatheter mitral valve repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024.

The Structural heart Replacement segment is dominated by Transcatheter valve replacement that held largest share in 2017 and expected to grow at a strong double digit CAGR from 2017 to 2024.

Among the Surgical valve replacement devices, Tissue valves held the largest share in 2017 and is expected to grow at a single digit CAGR from 2017 to 2024.

Among the Transcatheter valve replacement devices, Transcatheter Aortic Valve Replacement (TAVR) devices held the largest share and expected to grow at a medium double digit CAGR from 2017 to 2024 and Transcatheter Mitral Valve Replacement (TMVR) devices is expected to grow at a strong double digit CAGR from 2017 to 2024.

North America region held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among North America countries, U.S. held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024.

Europe held the second largest share and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among European countries, Germany held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024.

Asia-Pacific is expected to grow at a strong double digit CAGR from 2017 to 2024. Among APAC countries, Japan held the highest share in 2017 and is expected to grow at a strong double digit CAGR from 2017 to 2024.

RoW is expected to grow at a medium double digit CAGR from 2017 to 2024. Among RoW countries, Brazil held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024.

Companies Featured

Abbott Laboratories Atricure Balton Sp. z o.o. Bard Peripheral Vascular, Inc. BioVentrix, Inc. BOSTON Scientific Claret Medical Colibri Heart Valve, LLC Comed BV Cook medicals LLC Cryo life, Inc. Edward Lifesciences InterValve, Inc. JC Medicals JenaValve Technology GmbH Leman Cardiovascular LivaNova PLC Mardil Medicals Medtentia International Ltd Oy Medtronic PLC Mitralign MitrAssist Neochord Novostia SA NuMED, Inc. NVT Med AG Occlutech Thubrikar Aortic Valve, Inc. Toray Industries, Inc. TransCardiac Therapeutics, LLC TTKChitra HeartValve Valcare Medical W. L. Gore and Associates Xuzhou Yatai Scientific Co. Ltd. and many more...

Key Topics Covered

1 Executive Summary

2 Introduction

3 Market Analysis

4 Structural Heart Devices Global Market, by Product

5 Regional Analysis

6 Competitive Landscape

7 Major Companies

For more information about this report visit https://www.researchandmarkets.com/research/mqphhk/structural_heart?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180801005979/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices

KEYWORD:

INDUSTRY KEYWORD: SURGERY HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/01/2018 04:04 PM/DISC: 08/01/2018 04:04 PM

http://www.businesswire.com/news/home/20180801005979/en